Skip to main content

Emtricitabine, tenofovir alafenamide, darunavir en cobicistat

J - Antiinfectives For Systemic Use -> J05 - Antivirals For Systemic Use -> J05A - Direct Acting Antivirals -> J05AR - Combinations -> J05AR22 -  emtricitabine, tenofovir alafenamide, darunavir and cobicistat
Administration category: Free Medicine group: antiviral Brand name: Symtuza

Standard dosages

≥ 18 years
Weight ROA Load Dosage
ROA:
po
Load:
-
Dosage:
1pieces 1 dd

Kidney function

≥ 18 years
ROA GFR Dosage Interval Comments
ROA: po
GFR:
10 - 30
Dosage:
do not prescribe
Comments:
gebruik van het combinatiepreparaat wordt ontraden
GFR:
<10
Dosage:
do not prescribe
Comments:
gebruik van het combinatiepreparaat wordt ontraden
Renal elimination: afhankelijk van component

Renal function-replacement therapy

CAPD: vermijd gebruik van het combinatiepreparaat

Hemo dialysis: vermijd gebruik van het combinatiepreparaat

CAV / VVHD: vermijd gebruik van het combinatiepreparaat

Pregnancy

Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:

For individual advice, consult an expert on site.
Metadata

Swab vid: M-439085.2
Updated: 06/16/2019 - 20:05
Status: Published

External links
Menu position